NKF advises ZuriMED shareholders on sale to Stryker
NKF advised the shareholders of ZuriMED Technologies on the sale of the company to Stryker. The selling group comprises more than 100 institutional and private investors, surgeons and scientists.
About the target
ZuriMED developed the FiberLocker System, a commercialized technology for rotator cuff augmentation. It is designed to increase biomechanical strength, addressing a clinical need in rotator cuff repair.
The advisors
The NKF team was led by corporate/M&A partners Patrik Peyer and Roman Sturzenegger, working with senior associate Alexander Göbel, associates Melchior Ebener and Anastasia Herger, junior associate Nora Arpagaus (all corporate/M&A), partners Nicolas Birkhäuser (competition) and Janine Reudt-Demont (IP/life sciences & healthcare) and associate Lukas Poschung (competition).
ZuriMED’s shareholders were further advised by Mintz on U.S. law matters, and by PwC on tax matters. Deutsche Bank acted as financial advisor.
